Identifying the optimal cutoff point of Ki-67 in breast cancer: a single-center experience
Objective Ki-67 is associated with breast cancer subtypes, but the optimal cutoff point of Ki-67 has not been established in our center. We evaluated the cutoff point of Ki-67 in breast cancer and analyzed the associations among Ki-67, clinicopathological features, and prognosis. Methods The clinico...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2023-08-01
|
| Series: | Journal of International Medical Research |
| Online Access: | https://doi.org/10.1177/03000605231195468 |
| _version_ | 1797692966934937600 |
|---|---|
| author | Wang Li Ning Lu Caiping Chen Xiang Lu |
| author_facet | Wang Li Ning Lu Caiping Chen Xiang Lu |
| author_sort | Wang Li |
| collection | DOAJ |
| description | Objective Ki-67 is associated with breast cancer subtypes, but the optimal cutoff point of Ki-67 has not been established in our center. We evaluated the cutoff point of Ki-67 in breast cancer and analyzed the associations among Ki-67, clinicopathological features, and prognosis. Methods The clinicopathological data and prognostic information of patients with breast cancer treated in our center were retrospectively collected, and the optimal cutoff point of Ki-67 was determined by univariate and multivariate survival risk analyses. The cutoff point was used to group the patients, and the differences in the clinicopathological features and prognosis were analyzed between the two groups. Results In total, 609 patients with estrogen receptor-positive and human epidermal growth factor receptor 2-negative primary breast cancer were enrolled. The mean Ki-67 value was 22.3% ± 15.4%, the median was 20%, and a cutoff point of 30% was an independent factor influencing recurrence-free survival. When 30% was used as the cutoff point, patients with a Ki-67 value of ≤30% had a better prognosis and lower tumor malignancy. Conclusion The optimal cutoff point of Ki-67 in breast cancer in our center is 30%. |
| first_indexed | 2024-03-12T02:35:14Z |
| format | Article |
| id | doaj.art-d282d9f8785e43a8a395bbdca7393507 |
| institution | Directory Open Access Journal |
| issn | 1473-2300 |
| language | English |
| last_indexed | 2024-03-12T02:35:14Z |
| publishDate | 2023-08-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Journal of International Medical Research |
| spelling | doaj.art-d282d9f8785e43a8a395bbdca73935072023-09-04T20:33:24ZengSAGE PublishingJournal of International Medical Research1473-23002023-08-015110.1177/03000605231195468Identifying the optimal cutoff point of Ki-67 in breast cancer: a single-center experienceWang LiNing LuCaiping ChenXiang LuObjective Ki-67 is associated with breast cancer subtypes, but the optimal cutoff point of Ki-67 has not been established in our center. We evaluated the cutoff point of Ki-67 in breast cancer and analyzed the associations among Ki-67, clinicopathological features, and prognosis. Methods The clinicopathological data and prognostic information of patients with breast cancer treated in our center were retrospectively collected, and the optimal cutoff point of Ki-67 was determined by univariate and multivariate survival risk analyses. The cutoff point was used to group the patients, and the differences in the clinicopathological features and prognosis were analyzed between the two groups. Results In total, 609 patients with estrogen receptor-positive and human epidermal growth factor receptor 2-negative primary breast cancer were enrolled. The mean Ki-67 value was 22.3% ± 15.4%, the median was 20%, and a cutoff point of 30% was an independent factor influencing recurrence-free survival. When 30% was used as the cutoff point, patients with a Ki-67 value of ≤30% had a better prognosis and lower tumor malignancy. Conclusion The optimal cutoff point of Ki-67 in breast cancer in our center is 30%.https://doi.org/10.1177/03000605231195468 |
| spellingShingle | Wang Li Ning Lu Caiping Chen Xiang Lu Identifying the optimal cutoff point of Ki-67 in breast cancer: a single-center experience Journal of International Medical Research |
| title | Identifying the optimal cutoff point of Ki-67 in breast cancer: a single-center experience |
| title_full | Identifying the optimal cutoff point of Ki-67 in breast cancer: a single-center experience |
| title_fullStr | Identifying the optimal cutoff point of Ki-67 in breast cancer: a single-center experience |
| title_full_unstemmed | Identifying the optimal cutoff point of Ki-67 in breast cancer: a single-center experience |
| title_short | Identifying the optimal cutoff point of Ki-67 in breast cancer: a single-center experience |
| title_sort | identifying the optimal cutoff point of ki 67 in breast cancer a single center experience |
| url | https://doi.org/10.1177/03000605231195468 |
| work_keys_str_mv | AT wangli identifyingtheoptimalcutoffpointofki67inbreastcancerasinglecenterexperience AT ninglu identifyingtheoptimalcutoffpointofki67inbreastcancerasinglecenterexperience AT caipingchen identifyingtheoptimalcutoffpointofki67inbreastcancerasinglecenterexperience AT xianglu identifyingtheoptimalcutoffpointofki67inbreastcancerasinglecenterexperience |